Dr. Maria Chiara Mariencheck, MD

Dr. Mariencheck practices at Davie Surgery - Ophthalmology - HOPD in Bermuda Run, North Carolina.

Dr. Mariencheck's NPI, 1659348746, was assigned on March 7, 2006. Dr. Mariencheck graduated from University of Washington School of Medicine in 1994. Dr. Mariencheck holds North Carolina license 9800627.

Dr. Mariencheck's primary practice is Davie Surgery - Ophthalmology - HOPD, at 329 Nc Highway 801 N, Bermuda Run, NC 27006.

Dr. Mariencheck's primary practice is Davie Surgery - Ophthalmology - HOPD in Bermuda Run, North Carolina. Dr. Mariencheck is also affiliated with Atrium Health Wake Forest Baptist Medical Center. The medical group on file is Atrium Health Wake Forest Baptist. Dmand AI also links Dr. Mariencheck to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mariencheck practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Mariencheck's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dmand AI has Dr. Mariencheck's licenses on file in 2 states: North Carolina and Tennessee.

CMS data shows 2,610 Medicare services from Dr. Mariencheck across 12 procedure codes in 2024, for 697 Medicare patients. Medicare paid $77,498 for them. Every service was in an office.

CMS counts 697 Medicare patients who saw Dr. Mariencheck in 2024. The largest group is 65 to 74, with 339 patients. 70% of them have high blood pressure, and 70% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.10, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mariencheck's median patient age at 72, with 58% women.

In 2024, Dr. Mariencheck wrote 1,460 Medicare Part D claims for 525 patients. 81% of them were for generic drugs. CMS names the drug for 1,310 of them, across 34 drugs with 11 or more claims each, at $655,342 in total drug cost. In 2023, CMS named 1,175 claims across 31 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Mariencheck for performance year 2024, reported as part of a group. Dr. Mariencheck accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 737 procedures of removal of skin lesions by Dr. Mariencheck, more than 90% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 6 general payments to Dr. Mariencheck from 4 drug and device companies from 2016 to 2025. Education make up the largest share, 63% of the total. Janssen Pharmaceuticals, Inc paid the most, $121.

Dr. Mariencheck graduated from University of Washington School of Medicine in 1994.